<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_TOXREP962 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEgr7 jpg ?><?FILEgr8 jpg ?><?FILEgr9 jpg ?><?FILEgr10 jpg ?><?FILEgr11 jpg ?><?FILEgr12 jpg ?><?FILEgr13 jpg ?><?FILEgr14 jpg ?><?FILEgr15 jpg ?><?FILEga1 jpg ?><?FILEmmc1 zip ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxicol Rep</journal-id><journal-id journal-id-type="iso-abbrev">Toxicol Rep</journal-id><journal-title-group><journal-title>Toxicology Reports</journal-title></journal-title-group><issn pub-type="epub">2214-7500</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7509141</article-id><article-id pub-id-type="publisher-id">S2214-7500(20)30399-1</article-id><article-id pub-id-type="doi">10.1016/j.toxrep.2020.09.005</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Neuroprotective mechanism of <italic>Vernonia amygdalina</italic> in a rat model of neurodegenerative diseases</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Oladele</surname><given-names>Johnson O.</given-names></name><email>oladelejohn2007@gmail.com</email><email>jo.oladele@kingsuniversity.edu.ng</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Oyeleke</surname><given-names>Oyedotun M.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Oladele</surname><given-names>Oluwaseun T.</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Olaniyan</surname><given-names>Monisola</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><aff id="aff0005"><label>a</label>Biochemistry Unit, Department of Chemical Sciences, Faculty of Science, Kings University, Ode-Omu, Osun State, Nigeria</aff><aff id="aff0010"><label>b</label>Phytomedicine and Toxicology Laboratories, Department of Biochemistry, Faculty of Basic and Applied Sciences, Osun State University, Osogbo, Nigeria</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author. <email>oladelejohn2007@gmail.com</email><email>jo.oladele@kingsuniversity.edu.ng</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>14</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>14</day><month>9</month><year>2020</year></pub-date><volume>7</volume><fpage>1223</fpage><lpage>1232</lpage><history><date date-type="received"><day>3</day><month>2</month><year>2020</year></date><date date-type="rev-recd"><day>3</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>6</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Published by Elsevier B.V.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract abstract-type="graphical" id="abs0005"><title>Graphical abstract</title><p>Schematic illustration of the neuroprotective action of <italic>Curcuma longa</italic> in brain regions (midbrain, cerebrum, &#x00026; cerebellum) nitrobenzene-induced neurodegenerative rats. MPO: myeloperoxidase, NO: nitric oxide, AChE: acetylcholinesterase, DOPA: dopamine, GSH: glutathione, CAT: catalase, SOD: superoxide dismutase, LPO: lipid peroxidation, H<sub>2</sub>O<sub>2</sub>: hydrogen peroxide generation.</p><p><fig id="fig0080" position="anchor"><graphic xlink:href="ga1"/></fig></p></abstract><abstract abstract-type="author-highlights" id="abs0010"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><label>&#x02022;</label><p id="par0005">Nitrobenzene-induced neurodegenerative disease in rats with evidence of neurobehavioural deficits.</p></list-item><list-item id="lsti0010"><label>&#x02022;</label><p id="par0010">Nitrobenzene-mediate acetylcholinesterase activities in the brain regions of rats.</p></list-item><list-item id="lsti0015"><label>&#x02022;</label><p id="par0015">Exposure of nitrobenzene to rats caused oxidative stress in the brain of the rats.</p></list-item><list-item id="lsti0020"><label>&#x02022;</label><p id="par0020">Nitrobenzene-induced inflammation in midbrain, cerebrum and cerebellum of rats.</p></list-item><list-item id="lsti0025"><label>&#x02022;</label><p id="par0025"><italic>Vernonia amygdalina</italic> inhibited lipid peroxidation in the brain of neurodegenerative rats.</p></list-item><list-item id="lsti0030"><label>&#x02022;</label><p id="par0030">Neuroprotective mechanism of <italic>Vernonia amygdalina</italic> is <italic>via</italic> antioxidant, acetylcholinesterase suppression, lipid peroxidation inhibition, anti-inflammatory and neurobehavioural restoring abilities.</p></list-item></list></p></abstract><abstract id="abs0015"><p>The global upsurge in the prevalence of neurodegenerative diseases in recent years has been associated with increase in toxic chemical exposure and release into the biosystem, having over 46.8 million people suffer dementia worldwide. This study focused on elucidating the neuroprotective mechanism of methanol leaf extract of <italic>Vernonia amygdalina</italic> (MLVA) in nitrobenzene-induced neurodegenerative disease in rats. Thirty aged male rats were sorted into five groups of six rats each. Group A received distilled water while 100 mg/kg bw of nitrobenzene was orally administered to groups (B to E) to induce neurodegeneration. Group B (disease control) was untreated, while Group C and D were treated with oral administration of 200 and 400 mg/kg bw of MLVA respectively and group E with vitamin E for 14 days. Locomotor behaviour was analysed using video-tracking software while the midbrain, cerebrum and cerebellum of the rats were processed for biochemical analyses. Results showed that treatment of nitrobenzene-induced neurodegenerative rats with MLVA significantly (p &#x0003c; 0.05) increase dopamine, GSH, antioxidant enzymes levels; and decrease acetylcholinesterase activity, biomarkers of inflammatory and oxidative stress level. Also, MLVA enhanced neurobehavioural and locomotor activities in all markers assessed. Taken together, neuroprotective mechanisms of MLVA can be linked to its antioxidant, acetylcholinesterase suppression, lipid peroxidation inhibition, anti-inflammatory and neurobehavioural restoring abilities.</p></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Neurodegenerative diseases</kwd><kwd><italic>Vernonia amygdalina</italic></kwd><kwd>Acetylcholinesterase</kwd><kwd>Neurobehavioural test</kwd><kwd>Nitrobenzene</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><label>1</label><title>Introduction</title><p id="par0035">The occurrence of neurodegenerative diseases (NDs) is progressively increasing around the globe with more than 46.8 million people suffering from different kinds of the diseases. It is estimated that more than 10 million individuals with NDs will be domiciled in the top 10 most populous nation in the world including Nigeria by 2030 [<xref rid="bib0005" ref-type="bibr">[1]</xref>, <xref rid="bib0010" ref-type="bibr">[2]</xref>, <xref rid="bib0015" ref-type="bibr">[3]</xref>]. Some of the common risk factors of NDs includes exposure to environmental pollutants, oxidative stress, aging, head trauma, and protein dysfunction. Parkinson&#x02019;s disease (PD) is of two types: sporadic PD which is more than 90 % cases and familial PD. More than 20 genes have been implicated in parkinsonism [<xref rid="bib0315" ref-type="bibr">63</xref>]. Mutation in UCHL1 (ubiquitin C-terminal hydrolase 1), Parkin, DJ-1 or PINK1 (PTEN induced putative kinase 1) has been reported to cause autosomal recessive while autosomal dominant is caused by genetic mutation in &#x003b1;-syn or LRRK2 (leucine-rich repeat kinase 2) [<xref rid="bib0020" ref-type="bibr">4</xref>,<xref rid="bib0025" ref-type="bibr">5</xref>]. Furthermore, chromosome 2 and X have been strongly linked to PD susceptibility [<xref rid="bib0320" ref-type="bibr">64</xref>]. In both sporadic and familial types of the PD, &#x003b1;-Syn is considered a fundamental protein that participates in the molecular pathogenesis of the disease [<xref rid="bib0030" ref-type="bibr">6</xref>].</p><p id="par0040">Alzheimer&#x02019;s disease (AD) is referred to as the major root of dementia [<xref rid="bib0035" ref-type="bibr">7</xref>] which is characterized by an impairment of cognitive function especially the memory and the incapability to carryout daily activities [<xref rid="bib0040" ref-type="bibr">8</xref>]. The aggregation of amyloid beta (A&#x003b2;) plaques and neurofibrillary tau tangles (NFTs) in the brain neurons which interrupt nerve activities impulses is one of the established theories for AD aetiology. Glycogen synthase kinase 3&#x003b2; (GSK-3B) and phosphatases are kinase enzymes which enhance tau regulation by phosphorylation to perform its physiological function [<xref rid="bib0045" ref-type="bibr">9</xref>]. Several lysosomal disorders such as lysosomal storage disorder has been documented to result into failure of tau degradation which in turn leads to hyper-phosphorylation and ultimately cause formation of extracellular NFTs interrupting neural network thus, result into a pathological condition known as AD [<xref rid="bib0050" ref-type="bibr">10</xref>].</p><p id="par0045">The major pathological process which causes dopaminergic neurons death in NDs is yet fully understood. Recent scientific findings suggest the involvement of neuro-inflammation, microglial activation, oxidative stress, and apoptotic mechanisms in NDs pathology [<xref rid="bib0055" ref-type="bibr">11</xref>]. However, it is not yet fully elucidated whether one or more of these diseases mediators is responsible for initiating the disease. Building upon this, medicinal plants, their active components and extracts with multiple pharmacological mechanisms such as antioxidant, anti-apoptotic, and anti-inflammation are strongly recommended as potential neuroprotective agents.</p><p id="par0050">In this study, nitrobenzene was used to induced neurodegeneration in rats. It is a toxic industrial and environmental chemical which was first synthesized by treating benzene with fuming nitric acid in 1834 and was produced for commercial purpose in England in 1856. Since then, it has been produced in very large quantity across the globe due to its relevance in industrial and manufacturing activities [<xref rid="bib0060" ref-type="bibr">12</xref>]. Nitrobenzene and its chemical intermediates are employed in the production of nitrocellulose (pyroxylin), dyestuffs, and in in refining lubricating oils [<xref rid="bib0065" ref-type="bibr">13</xref>]. A range of typical symptoms of nitrobenzene toxicosis including weakness, nausea, hyperalgesia, headache, dyspnoea, and cyanosis [<xref rid="bib0070" ref-type="bibr">14</xref>]. These symptoms are neuronal related thus suggesting that nitrobenzene may have capacity to interfere with the normal neurological processes.</p><p id="par0055">The current available clinical interventions for the treatment of these NDs are only palliatives with associated adverse effects [<xref rid="bib0075" ref-type="bibr">15</xref>], thus there is a need for a new, non-invasive, non-toxic and non-expensive treatment for the diseases. Phytochemicals and natural products of plant origin have been considered to have great beneficial effects to human health and help in the prevention and treatment of many diseases including neurodegenerative disorders [<xref rid="bib0080" ref-type="bibr">[16]</xref>, <xref rid="bib0085" ref-type="bibr">[17]</xref>, <xref rid="bib0090" ref-type="bibr">[18]</xref>]. <italic>Vernonia amygdalina</italic> is medicinal plant used traditionally in the treatment and treatment of different diseases [<xref rid="bib0325" ref-type="bibr">65</xref>,<xref rid="bib0330" ref-type="bibr">66</xref>]. The documented phytochemical constituents of various fractions of <italic>Vernonia amygdalina</italic> includes epivernodalol, sesquiterpene lactones, elemanolide [<xref rid="bib0095" ref-type="bibr">19</xref>], edotides [<xref rid="bib0100" ref-type="bibr">20</xref>], terpenes, steroids, coumarins, flavonoids, phenolic acids, lignans, xanthones and anthraquinone [<xref rid="bib0105" ref-type="bibr">21</xref>], saponins and alkaloids [<xref rid="bib0110" ref-type="bibr">22</xref>]. Documented pharmacological actions of these phytochemical constituents include antioxidant properties [<xref rid="bib0115" ref-type="bibr">23</xref>], anti-inflammatory [<xref rid="bib0120" ref-type="bibr">24</xref>].</p><p id="par0060">This study aimed at investigating the protective effects of methanolic leaf extract of <italic>Vernonia amygdalina</italic> on nitrobenzene-induced neurotoxicity by assessing some locomotor activities and exploratory profiles in experimental rats using standard behavioural protocols and a video-tracking software. Moreover, in order to further understand the neuroprotective mechanisms of the extract in nitrobenzene-induced neurodegeneration in rats, assessment of oxidative stress and inflammatory indices in addition to acetylcholinesterase (AChE), lipid peroxidation and antioxidant enzymes activities were carried out in the midbrain, cerebrum and cerebellum of the treated rats.</p></sec><sec id="sec0010"><label>2</label><title>Materials and methods</title><sec id="sec0015"><label>2.1</label><title>Chemicals and reagents</title><p id="par0065">Vitamin E (Alpha Tocopherol) is a product of Embassy pharmaceuticals, Nigeria. High purity (&#x0003c; 99.7 %) Nitrobenzene was obtained from BDH chemical Poole England. Methanol, all other chemicals and reagents are of analytical grade obtained from both Sigma-Aldrich Co. St Louis, Missouri, USA and Analar BDH Limited, Poole, England.</p></sec><sec id="sec0020"><label>2.2</label><title><italic>Vernonia amygdalina</italic></title><p id="par0070">Fresh leaves of <italic>Vernonia amygdalina</italic> were sourced in a garden at the staff quarters in Kings University, Odeomu, Osun State. The leaf has been identified at IFE-Herbarium of Botany Department, Obafemi Awolowo University, Ile-Ife with Voucher number. The <italic>Vernonia amygdalina</italic> leaves were dried in the Biochemistry laboratory at room temperature and subsequently pulverized. Thereafter, the sample was defatted in n-hexane using Soxhlet apparatus. The methanol extract used for the study was prepared by extracting the defatted <italic>Vernonia amygdalina</italic> sample for 72 h in 90 % methanol. The resulting mixture was filtered and the filtrate concentrated extract was obtained on water bath. The paste obtained was freeze dried, weighed and reconstituted in water for subsequent studies.</p></sec><sec id="sec0025"><label>2.3</label><title>Phytochemical analysis of <italic>Vernonia amygdalina</italic></title><p id="par0075">Phytochemical analysis was carried out on methanol leaf extract of <italic>Vernonia amygdalina</italic> using standard procedures as described by Harborne [<xref rid="bib0125" ref-type="bibr">25</xref>]. Procedure of Van Buren and Robinson [<xref rid="bib0130" ref-type="bibr">26</xref>] was followed for the quantification of tannin content. The total phenol content was determined according to Singleton et al. [<xref rid="bib0135" ref-type="bibr">27</xref>] while total terpenoids in the extract was determined by method of Ferguson [<xref rid="bib0140" ref-type="bibr">28</xref>]. Alkaloids were quantified by following the procedure of Harborne [<xref rid="bib0125" ref-type="bibr">25</xref>]. Saponins were quantified following the methodology of Obadoni and Ochuko [<xref rid="bib0145" ref-type="bibr">29</xref>], and total flavonoid content was determined according to protocol described by Meda et al. [<xref rid="bib0150" ref-type="bibr">30</xref>].</p></sec><sec id="sec0030"><label>2.4</label><title>Experimental animals</title><p id="par0080">Thirty matured 4&#x02013;5 months old male Wistar strain albino rats were used in the study. The rats were sourced and raised at the Biochemistry breeding colony of the Biochemistry unit, Department of Chemical Sciences, Kings University, Ode-Omu, Osun state, Nigeria. Animals were kept under ambient standard conditions (25 <bold>&#x000b1;</bold> 2 &#x000b0;C and relative humidity of 50 <bold>&#x000b1;</bold> 15 %) in stainless steel cages and metabolic wastes were cleaned twice daily. The rats were allowed to acclimatize to these conditions for fourteen days and were exposed to 12 h daylight and darkness cycle, fed with commercially available rat pellet and water <italic>ad libitum.</italic> The experiment was carried out in accordance with current rules and guidelines that have been established for the care of the laboratory animals [<xref rid="bib0155" ref-type="bibr">31</xref>] with number 2019/001. The rats were grouped into five groups containing six rats each.</p><p id="par0085"><bold>Group A:</bold> received distilled water daily and serve as the Control.</p><p id="par0090"><bold>Group B:</bold> received 100 mg/kg Nitrobenzene orally.</p><p id="par0095"><bold>Group C:</bold> received 100 mg/kg Nitrobenzene and 200 mg/kg <italic>Vernonia amygdalina</italic></p><p id="par0100"><bold>Group D:</bold> received 100 mg/kg Nitrobenzene and 400 mg/kg <italic>Vernonia amygdalina</italic></p><p id="par0105"><bold>Group E:</bold> received 100 mg/kg Nitrobenzene and 400 mg/kg Vitamin E</p><p id="par0110">Treatments were administered to the rats orally for 14 consecutive days.</p></sec><sec id="sec0035"><label>2.5</label><title>Preparation of brain homogenates</title><p id="par0115">The brains were immediately excised and blotted to remove blood stains. They were cleansed and rinsed in 1.15 % KCl on ice to remove haemoglobin, then weighed. They were immediately sectioned into cerebrum, cerebellum, and midbrain then homogenized in four volumes of the homogenizing buffer (10 mM potassium phosphate buffer, pH 7.4) using a Teflon homogenizer. The homogenates were centrifuged at 12,500<italic>g</italic> for 15 min in a cold centrifuge (4 &#x02103;) to obtain the post mitochondrial fractions which collected and used for biochemical analyses.</p></sec><sec id="sec0040"><label>2.6</label><title>Measurement of biochemical markers</title><p id="par0120">Acetylcholinesterase (AChE) activities in the three regions of the brain was evaluated using the protocol documented by Ellman et al. [<xref rid="bib0160" ref-type="bibr">32</xref>]. The protein content of the homogenates was determined using BSA as a standard in the protocol described by Lowry et al. [<xref rid="bib0165" ref-type="bibr">33</xref>]. Nitric oxide (NO) level was assessed by procedure reported by Green et al. [<xref rid="bib0170" ref-type="bibr">34</xref>]. The concentration of dopamine was evaluated using procedure described by Guo et al. [<xref rid="bib0175" ref-type="bibr">35</xref>]. Myeloperoxidase (MPO) activity in the homogenate was quantified following the method of Granell et al. [<xref rid="bib0180" ref-type="bibr">36</xref>]. Lipid peroxidation was evaluated by monitoring the level of MDA using procedure reported by Varshney and Kale [<xref rid="bib0185" ref-type="bibr">37</xref>]. Superoxide dismutase (SOD) activity was evaluated following the inhibition of adrenaline auto-oxidation in a basic milieu as described by Misra and Fridovich, [<xref rid="bib0190" ref-type="bibr">38</xref>]. The reduced GSH content in the brain samples was determined using the protocol reported by Buetler et al. [<xref rid="bib0195" ref-type="bibr">39</xref>]. Hydrogen peroxide generation was assayed oxidation of ferrous ions and sorbitol colour amplification system using the method of Wolff, [<xref rid="bib0200" ref-type="bibr">40</xref>]. Catalase (CAT) activity was determined following the protocol documented by Clairborne [<xref rid="bib0205" ref-type="bibr">41</xref>] using hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) as a substrate.</p></sec><sec id="sec0045"><label>2.7</label><title>Neurobehavioural assessment</title><p id="par0125">Behavioural assessments to evaluate the motor, exploratory, locomotory, and neuromuscular changes associated with the treatments were conducted 24 h after the last dosage was administered. Open field assessment was used to determine the total distance travelled, total time spent, body angle turn, and average speed as analysed by video tracking software (EthoWatcher). Fore limb grip test, and negative geotaxis using the methods documented by Farombi et al. [<xref rid="bib0080" ref-type="bibr">16</xref>].</p></sec><sec id="sec0050"><label>2.8</label><title>Histological examination</title><p id="par0130">The brains sections were fixed in 10 % formalin and embedded in paraffin wax. Thin sections (7&#x02013;9 mm thickness) of the liver and kidney tissues were cut and dewaxed in xylene, hydrated in decreasing percentage of alcohol and stained with hematoxylin and eosin (H &#x00026; E). They were differentiated in 90 % alcohol and cleared in xylene. These stained sections were observed under the microscope for histopathological analysis.</p></sec><sec id="sec0055"><label>2.9</label><title>Statistical analysis</title><p id="par0135">Results obtained were expressed as mean &#x000b1; standard error of mean (mean &#x000b1; SD) and analysed using one-way analysis of variance (ANOVA) with the aid of SPSS 22.0 computer software package (SPSS Inc; Chicago, U.S.A) to compare the experimental groups followed by Bonferroni&#x02019;s post-hoc test. Values at P &#x0003c; 0.05 were considered significant.</p></sec></sec><sec id="sec0060"><label>3</label><title>Results</title><sec id="sec0065"><label>3.1</label><title>Phytochemical constituent of methanol leaf extract of <italic>Vernonia amygdalina</italic> (MLVA)</title><p id="par0140">The phytochemical screening results revealed the presence of anthraquinone, saponins, alkaloids, flavonoids, lignans, xanthones, cardiac glycosides, terpenes, steroids, coumarins, phenols, tannins and terpenoids as constituent phytochemicals of methanol leaf extract of <italic>Vernonia amygdalina</italic>. However, as depicted in <xref rid="tbl0005" ref-type="table">Table 1</xref>, the total flavonoid content of the extract is 108.25 mg/g Catechin equivalent, the total phenol content is 189.52 mg/g Gallic acid equivalent, the tannin content is 146.33 mg/g Gallic acid equivalent while the alkaloids, saponins and total terpenoids are 11.77, 7.52 and 10.71 % yield per gram respectively.<table-wrap position="float" id="tbl0005"><label>Table 1</label><caption><p>Phytochemical constituents of methanol leaf extract of <italic>Vernonia amygdalina.</italic></p></caption><alt-text id="at0195">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">S/N</th><th align="left">Phytochemical constituents</th><th align="left">Amount</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Total flavonoid (Catechin eq. [mg/g])</td><td align="left">108.25 &#x000b1; 12.73</td></tr><tr><td align="left">2</td><td align="left">Total phenol (Gallic acid eq. [mg/g])</td><td align="left">189.52 &#x000b1; 6.11</td></tr><tr><td align="left">3</td><td align="left">Tannin content (Gallic acid eq. [mg/g])</td><td align="left">146.33 &#x000b1; 8.64</td></tr><tr><td align="left">4</td><td align="left">Alkaloids (Percentage (%) yield per gram)</td><td align="left">11.77 &#x000b1; 1.85</td></tr><tr><td align="left">5</td><td align="left">Saponins (% yield per gram)</td><td align="left">7.52 &#x000b1; 0.96</td></tr><tr><td align="left">6</td><td align="left">Total terpenoids (% yield per gram)</td><td align="left">10.71 &#x000b1; 0.55</td></tr></tbody></table></table-wrap></p></sec><sec id="sec0070"><label>3.2</label><title>Effects of MLVA on growth rate, brain weight and body weight of nitrobenzene-induced neurodegenerative rats</title><p id="par0145"><xref rid="tbl0010" ref-type="table">Table 2</xref> shows that there is a significant (P &#x0003c; 0.05) decrease in the total body weight gained and brain weights of the rats treated with nitrobenzene alone. The decrease in growth rate of the experimental animals (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>) also corroborates the observed decline in the total body weight gained and protein content (<xref rid="fig0055" ref-type="fig">Fig. 11</xref>) of the rats administered with nitrobenzene only. Treatment of the rats with either MLVA or Vitamin E reverse these decrease and enhance the rats&#x02019; growth beyond those in the control group.<table-wrap position="float" id="tbl0010"><label>Table 2</label><caption><p>Effects of MLVA on body weight gain, and brain weight of nitrobenzene-induced neurodegenerative rats.</p></caption><alt-text id="at0200">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Groups</th><th align="left">Body weight gain (g)</th><th align="left">Brain weight (g)</th></tr></thead><tbody><tr><td align="left">Group A</td><td align="left">11.96 &#x000b1; 2.38</td><td align="left">1.40 &#x000b1; 0.32</td></tr><tr><td align="left">Group B</td><td align="left">6.36 &#x000b1; 1.03<sup>a</sup></td><td align="left">1.44 &#x000b1; 0.46<sup>a</sup></td></tr><tr><td align="left">Group C</td><td align="left">15.85 &#x000b1; 1.39<sup>ab</sup></td><td align="left">1.38 &#x000b1; 0.40<sup>ab</sup></td></tr><tr><td align="left">Group D</td><td align="left">18.66 &#x000b1; 1.92<sup>ab</sup></td><td align="left">1.40 &#x000b1; 0.37<sup>b</sup></td></tr><tr><td align="left">Group E</td><td align="left">20.77 &#x000b1; 2.23<sup>ab</sup></td><td align="left">1.35 &#x000b1; 0.39<sup>ab</sup></td></tr></tbody></table><table-wrap-foot><fn><p>Data are given as mean &#x000b1; SD of rats per group. n = 6. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></fn></table-wrap-foot></table-wrap><fig id="fig0005"><label>Fig. 1</label><caption><p>Effects of MLVA on growth rate of rats treated with nitrobenzene.</p><p>Data are given as mean &#x000b1; SD of rats per group. n = 6. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina.</italic> Group A (control), group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0120">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig></p></sec><sec id="sec0075"><label>3.3</label><title>MLVA enhanced behavioural, exploratory and locomotor activities of nitrobenzene-induced neurodegenerative rats</title><p id="par0150"><xref rid="tbl0015" ref-type="table">Table 3</xref> shows the results of behavioural analyses of the general locomotor activities, negative geotaxis, forelimb grip, time of grooming and incidence of faecal pellets in nitrobenzene-induced neurodegenerative rats. Rats treated with nitrobenzene alone demonstrated significant (p &#x0003c; 0.05) decrease in the total distance travelled, average speed, total time mobile, and turn angle in comparison with control. However, treatment of the rats with either MLVA or Vitamin E showed significant improvement in the motor and locomotor activities evidenced by marked increase in the average speed, total distance travelled, total time mobile and turn angle when compared with untreated neurodegenerative rats. Moreover, Rats treated with nitrobenzene alone exhibited a significant lesser time in forelimb grip test and marked decrease in time of grooming and incidence of faecal pellets than the control. Treatment of the rats with either MLVA or Vitamin E showed marked increase in rat activities on the forelimb grip, time of grooming and faecal pellets when compared with the control.<table-wrap position="float" id="tbl0015"><label>Table 3</label><caption><p>Effects of MLVA on neurobehavioral and exploratory activities of nitrobenzene-induced neurodegenerative rats.</p></caption><alt-text id="at0205">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group A</th><th align="left">Group B</th><th align="left">Group C</th><th align="left">Group D</th><th align="left">Group E</th></tr></thead><tbody><tr><td align="left">Total distance travelled (cm)</td><td align="left">93.65 &#x000b1; 0.13</td><td align="left">50.43 &#x000b1; 0.47 <sup>a</sup></td><td align="left">85.33 &#x000b1; 2.80<sup>ab</sup></td><td align="left">92.87 &#x000b1; 3.11 <sup>b</sup></td><td align="left">89.25 &#x000b1; 6.01 <sup>b</sup></td></tr><tr><td align="left">Total time (Sec)</td><td align="left">306.10 &#x000b1; 8.32</td><td align="left">253.90 &#x000b1; 12.40<sup>a</sup></td><td align="left">315.90 &#x000b1; 17.64 <sup>ab</sup></td><td align="left">330.18 &#x000b1; 9.10 <sup>ab</sup></td><td align="left">323.05 &#x000b1; 7.50 <sup>ab</sup></td></tr><tr><td align="left">Body angle turn</td><td align="left">6.03 &#x000b1; 0.17</td><td align="left">11.05 &#x000b1; 0.52 <sup>a</sup></td><td align="left">12.79 &#x000b1; 0.38 <sup>ab</sup></td><td align="left">9.29 &#x000b1; 0.75 <sup>ab</sup></td><td align="left">10.16 &#x000b1; 0.12 <sup>ab</sup></td></tr><tr><td align="left">Average speed (cm/sec)</td><td align="left">0.31 &#x000b1; 0.06</td><td align="left">0.20 &#x000b1; 0.03<sup>a</sup></td><td align="left">0.27 &#x000b1; 0.03<sup>ab</sup></td><td align="left">0.28 &#x000b1; 0.04<sup>ab</sup></td><td align="left">0.28 &#x000b1; 0.05 <sup>ab</sup></td></tr><tr><td align="left">Grooming (Sec)</td><td align="left">76.50 &#x000b1; 7.85</td><td align="left">10.65 &#x000b1; 4.13 <sup>a</sup></td><td align="left">85.40 &#x000b1; 13.02 <sup>ab</sup></td><td align="left">91.35 &#x000b1; 17.48 <sup>ab</sup></td><td align="left">88.10 &#x000b1; 12.64 <sup>ab</sup></td></tr><tr><td align="left">Negative geotaxis (Sec)</td><td align="left">1.40 &#x000b1; 0.38</td><td align="left">5.80 &#x000b1; 1.95 <sup>a</sup></td><td align="left">1.90 &#x000b1; 0.84 <sup>ab</sup></td><td align="left">1.50 &#x000b1; 0.72 <sup>b</sup></td><td align="left">1.70 &#x000b1; 0.46 <sup>ab</sup></td></tr><tr><td align="left">Fecal pellets (frequency)</td><td align="left">1.10 &#x000b1; 0.35</td><td align="left">1.60 &#x000b1; 0.45 <sup>a</sup></td><td align="left">1.20 &#x000b1; 0.50 <sup>a</sup></td><td align="left">1.50 &#x000b1; 0.60 <sup>a</sup></td><td align="left">1.40 &#x000b1; 0.50 <sup>ab</sup></td></tr><tr><td align="left">Fore-limb grip (Sec)</td><td align="left">47.50 &#x000b1; 13.42</td><td align="left">16.35 &#x000b1; 5.61 <sup>a</sup></td><td align="left">55.60 &#x000b1; 9.48 <sup>ab</sup></td><td align="left">59.00 &#x000b1; 12.60 <sup>ab</sup></td><td align="left">52.80 &#x000b1; 10.42 <sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec0080"><label>3.4</label><title>MLVA repressed inflammatory activity in brain sections of nitrobenzene-induced neurodegenerative rats</title><p id="par0155">The effects of MLVA on neuro-inflammation in mid brain, cerebrum and cerebellum of the experimental rats was evaluated by measuring MPO activities and NO concentration level. Rats administered nitrobenzene alone demonstrated a marked increase in NO level and MPO activities in all the brain sections when compared with the control (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>, <xref rid="fig0015" ref-type="fig">Fig. 3</xref>). However, treatment with of 200 and 400 mg/kg of MLVA or Vitamin E significantly attenuated both NO and MPO levels in the midbrain, cerebrum and cerebellum when compared with control.<fig id="fig0010"><label>Fig. 2</label><caption><p>Effect of MLVA on nitric oxide level in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0125">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig><fig id="fig0015"><label>Fig. 3</label><caption><p>Effect of MLVA on myeloperoxidase (MPO) activities level in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0130">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec0085"><label>3.5</label><title>Effects of MLVA on acetylcholinesterase activity and dopamine level in nitrobenzene-induced neurodegenerative rats</title><p id="par0160"><xref rid="fig0020" ref-type="fig">Fig. 4</xref>, <xref rid="fig0025" ref-type="fig">Fig. 5</xref> showed the ameliorating potentials of MLVA on the AChE activity and dopamine level in the three brain regions of the experimental rats. Exposure of rats to nitrobenzene alone caused significant (p &#x0003c; 0.05) decrease in dopamine concentration and elevation in AChE activity in the midbrain, cerebrum and cerebellum of the rats. However, treatment with either MLVA and vitamin E significantly (p &#x0003c; 0.05) reversed the AChE activity when compared with the control and enhance dopamine concentrations in all regions of the brain examined.<fig id="fig0020"><label>Fig. 4</label><caption><p>Effect of MLVA on acetylcholinesterase (AChE) activities level in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0135">Fig. 4</alt-text><graphic xlink:href="gr4"/></fig><fig id="fig0025"><label>Fig. 5</label><caption><p>Effect of MLVA on dopamine level in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0140">Fig. 5</alt-text><graphic xlink:href="gr5"/></fig></p></sec><sec id="sec0090"><label>3.6</label><title>MLVA improved glutathione level and antioxidant enzymes activities in brain sections of nitrobenzene-induced neurodegenerative rats</title><p id="par0165"><xref rid="fig0030" ref-type="fig">Fig. 6</xref>, <xref rid="fig0035" ref-type="fig">Fig. 7</xref>, <xref rid="fig0040" ref-type="fig">Fig. 8</xref> shows the glutathione level and antioxidant activities of CAT and SOD in the midbrain, cerebrum and cerebellum of experimental rats. Administration of rat with nitrobenzene alone showed caused a significant decrease (p &#x0003c; 0.05) in GSH level and decline in activities of CAT and SOD when compared with the control. However, treatment with 200 and 400 mg/kg of MLVA or Vitamin E significantly increased the GSH level and enhance all the enzyme.<fig id="fig0030"><label>Fig. 6</label><caption><p>Effect of MLVA on reduced glutathione (GSH) content in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0145">Fig. 6</alt-text><graphic xlink:href="gr6"/></fig><fig id="fig0035"><label>Fig. 7</label><caption><p>Effect of MLVA on catalase (CAT) activities in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0150">Fig. 7</alt-text><graphic xlink:href="gr7"/></fig><fig id="fig0040"><label>Fig. 8</label><caption><p>Effect of MLVA on superoxide dismutase (SOD) activities in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0155">Fig. 8</alt-text><graphic xlink:href="gr8"/></fig></p></sec><sec id="sec0095"><label>3.7</label><title>MLVA suppressed lipid peroxidation and hydrogen peroxide generation in brain sections of nitrobenzene-induced neurodegenerative rats</title><p id="par0170">Figs. <xref rid="fig0045" ref-type="fig">9</xref> and <xref rid="fig0050" ref-type="fig">10</xref> showed the results of neuronal oxidative stress biomarkers carried out in the midbrain, cerebrum and cerebellum of experimental rats. There was a marked increase in MDA level (an index of lipid peroxidation) and H<sub>2</sub>O<sub>2</sub> generation in the midbrain, cerebrum and cerebellum of rats administered nitrobenzene only when compared with the control group. Upon treatment with 200 and 400 mg/kg of MLVA or Vitamin E, there is was a significant decrease (p &#x0003c; 0.05) in both MDA and H<sub>2</sub>O<sub>2</sub> generation levels in the regions of the brain assessed.<fig id="fig0045"><label>Fig. 9</label><caption><p>Effect of MLVA on lipid peroxidation (MDA) levels in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0160">Fig. 9</alt-text><graphic xlink:href="gr9"/></fig><fig id="fig0050"><label>Fig. 10</label><caption><p>Effect of MLVA on hydrogen peroxide generation (H<sub>2</sub>O<sub>2</sub>) levels in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0165">Fig. 10</alt-text><graphic xlink:href="gr10"/></fig></p></sec><sec id="sec0100"><label>3.8</label><title>Reversal effects of MLVA on histological alterations in brain sections of nitrobenzene-induced neurodegenerative rats</title><p id="par0175">Figs. <xref rid="fig0060" ref-type="fig">12&#x02013;15</xref> show the histological alterations seen with the light microscope in the hippocampus, midbrain, cerebrum and cerebellum sections of brains of the experimental rats. The cytoarchitecture and morphology of hippocampus, midbrain, cerebrum and cerebellum of rats from control group appeared normal. However, obvious pathological lesions were observed in the hippocampus, midbrain, cerebellum and cerebrum sections of nitrobenzene group. In cerebellar cortex (<xref rid="fig0060" ref-type="fig">Fig. 12</xref>), group B show mild degenerative characterized with loss of cells from the purkinje cell layer and gradual loss of cytoplasmic contents, fragmented granule cell layer as well loss of major parts of the neuropil (red arrows). Group E showed a mild similar appearance with A and D group (yellow arrow). In cerebral prefrontal cortex (<xref rid="fig0065" ref-type="fig">Fig. 13</xref>), Group B treatment caused some observable degenerative changes in the cortex that was characterized by clustered pyknotic pyramidal neurons that appear with fragmented cytoplasm and condensed nuclei within soma (red arrow). Perineural spaces can be seen surrounding degenerating neurons (red arrows) Axons and dendrites are scarcely appreciable around neurons in this group. Also, nuclear content and cytoplasmic materials are less appreciable. In hippocampus (<xref rid="fig0070" ref-type="fig">Fig. 14</xref>), group B treatment on the other hand, induced degenerative changes in the hippocampus and was characterised by fragmented pyramidal and granule cell layer. Although group C and E showed slight degenerative changes in line with the morphologic appearance of groups B; their cortical layers are better structured and delineated like group A and D. In midbrain (<xref rid="fig0075" ref-type="fig">Fig. 15</xref>), Plates with marked morphological alteration is indicated by red arrow while yellow arrow indicates plate with mild morphological alteration. Plate with no observable alteration is indicated by black arrow.<fig id="fig0055"><label>Fig. 11</label><caption><p>Effect of MLVA on protein contents in brain regions of nitrobenzene-induced neurodegenerative rats.</p><p>Data are given as mean &#x000b1; SD of rats per group. MLVA: methanolic leaf extract of <italic>Vernonia amygdalina</italic>, a: Values differ significantly from group A (control) (P &#x0003c; 0.05). b: Values differ significantly from group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0170">Fig. 11</alt-text><graphic xlink:href="gr11"/></fig><fig id="fig0060"><label>Fig. 12</label><caption><p>Representative histological sections of panoramic views of cerebellar cortex of experimental rats. H &#x00026; E stain (<italic>x40, x100 and x400 magnification respectively</italic>). Molecular layer (M), purkinje cell layer (P), granule cell layer (G) and the medullary layer of white matter (W). Group A (control), group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0175">Fig. 12</alt-text><graphic xlink:href="gr12"/></fig><fig id="fig0065"><label>Fig. 13</label><caption><p>Representative histological sections of panoramic views of cerebral prefrontal cortex of experimental rats. H &#x00026; E stain (<italic>x40, x100 and x400 magnification respectively</italic>). The molecular layer (I), External granular layer (II), External pyramidal layer (III), Internal granular layer (IV), Internal pyramidal layer (V) and the multiform layer (VI) are demonstrated across study groups A&#x02013;E (arrow head direction). Group A (control), group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0180">Fig. 13</alt-text><graphic xlink:href="gr13"/></fig><fig id="fig0070"><label>Fig. 14</label><caption><p>Representative histological sections of panoramic views of hippocampus of experimental rats. H &#x00026; E stain (<italic>x40, x100 and x400 magnification respectively</italic>). The Dentate gyrus (DG) composed of granule cells, Cornu amonus {CA (1-3)} containing pyramidal cells, are well demonstrated across the study groups. Group A (control), group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0185">Fig. 14</alt-text><graphic xlink:href="gr14"/></fig><fig id="fig0075"><label>Fig. 15</label><caption><p>Representative histological sections of experimental rats&#x02019; midbrain showing regions of magnocellular red nucleus of nerve cells with large prominent pale indented nuclei, prominent nucleoli, fusiform and pyramidal nerve cells are seen. Cell processes are seen as well as some neuroglia. H &#x00026; E stain (<italic>x400 magnification</italic>). Group A (control), group B (nitrobenzene[NB] only); group C (NB + 200 MLVA), group D (NB + 400 MLVA); group E (NB + 400 MLVA).</p></caption><alt-text id="at0190">Fig. 15</alt-text><graphic xlink:href="gr15"/></fig></p></sec></sec><sec id="sec0105"><label>4</label><title>Discussion</title><p id="par0180">The upsurge in the prevalence of neurotoxicity induced by exposure to harmful chemicals is a major global health challenge [<xref rid="bib0335" ref-type="bibr">67</xref>,<xref rid="bib0340" ref-type="bibr">68</xref>]. Several characteristic factors such as dopamine depletion, increase in oxidative stress, acetylcholinesterase (AChE) activity, genetic mutations, aggregation of toxic misfolded proteins, proteosomal dysfunction, decrease in acetylcholine (ACh), brain-derived neurotrophic factor (BDNF) in the brain are involved in aetiology of NDs [<xref rid="bib0030" ref-type="bibr">6</xref>,<xref rid="bib0210" ref-type="bibr">42</xref>]. Preclinical trials on drug candidates have revealed several mechanisms underlying the observed neuroprotective effects of medicinal plants and their extracts, such as anti-inflammatory, anti-apoptotic, antioxidant, and specific neurotrophic mechanisms [<xref rid="bib0215" ref-type="bibr">43</xref>]. Molecular elucidation of these mechanisms will enhance discovery of novel neuroprotective agents for NDs. Thus, prophylactic approach using phytochemical may offer a significant clinical intervention in these pathological conditions.</p><p id="par0185">This present study demonstrated that methanol leaf extract of <italic>Vernonia amygdalina</italic> has remarkable protective effects in the treatment of biochemical and neurobehavioural deficits in rats exposed to neuro-toxicants. Results from this study revealed that there was a drastic reduction in brain weight of rats administered with nitrobenzene alone with concomitant decrease in the total body weight gained. Several experimental reports have demonstrated chemical toxicities lead to significant brain and body weight loss in rats if left untreated over time [<xref rid="bib0080" ref-type="bibr">16</xref>,<xref rid="bib0220" ref-type="bibr">44</xref>,<xref rid="bib0225" ref-type="bibr">45</xref>]. The observed reduction in the brain and body weight can be caused by depletion of nutrients, alteration of metabolic activities or pathways and inhibition in protein synthesis [<xref rid="bib0220" ref-type="bibr">44</xref>]. However, administration of 100 and 200 mg/kg body weight of methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly increase both the brain and body weight of the rat to normal. This suggested the ability of the extract to improve metabolic activities and enhance protein synthesis in the brain.</p><p id="par0190">In this study, experimental animals exposed to nitrobenzene alone demonstrated notable locomotor alterations as shown by decrease in speed, total mobility time and total distance covered. Furthermore, there is significant decline in the forelimb grip, body rotation and turn angle which are essential psychomotor coordination tools to assess neurodegenerative disorders [<xref rid="bib0230" ref-type="bibr">46</xref>,<xref rid="bib0235" ref-type="bibr">47</xref>]. The observed decrease in these locomotor markers implies dysfunction in the cellular signalling between nervous system and muscular junctions. Treatment with methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly increase all these markers indicating their abilities to reverse chemically mediated psychomotor dysfunctions in rats. Grooming in rats is a standard neurobehavioural index to evaluate alterations in behavioural patterns and psychomotor activities in rats [<xref rid="bib0240" ref-type="bibr">48</xref>]. Therefore, the role of methanol leaf extract of <italic>Vernonia amygdalina</italic> in reversing nitrobenzene-induced decrease in grooming time further potentiate beneficial effects of the extract against psychomotor deficiency in rats.</p><p id="par0195">Similarly, rats administered nitrobenzene only exhibited marked neuro-behavioural deficits as revealed by decrease in the exploratory activities and increased in frequency of faecal pellets. Exploratory activities and frequency of faecal pellets are parameters used to determined anxiogenic-like phenotype and behavioural imbalance in rats [<xref rid="bib0245" ref-type="bibr">49</xref>]. Treatment with 100 and 200 mg/kg body weight of methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly influence the behavioural activities of the rats by enhancing the exploratory events. This confirm the neuro-behavioural benefits of the extract.</p><p id="par0200">In this study, exposure of rats to nitrobenzene induced significant increase in the level of malondialdehyde (MDA) as marker of lipid peroxidation; and marked increase in NO and MPO as markers of inflammatory respectively in the three regions (cerebrum, cerebellum, and mid brain) of the brain. Neuronal cells are more vulnerable to oxidative stress and inflammation, thus, requires efficient steady supply of potent antioxidants to neutralize the lipid peroxidation chain reaction, which induces free radical damage. Treatment with methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly reverse the increase thus, inhibiting the lipid peroxidation chain reaction and neuro-inflammation in the three regions of the brain examined. These findings corroborate the report of Layer and Gomez-pinilla [<xref rid="bib0250" ref-type="bibr">50</xref>] that exogenous antioxidants obtained from plants or other natural products influence brain function and health.</p><p id="par0205">Acetylcholine is an essential neurotransmitter in the cholinergic system which play a major role in both central nervous system and peripheral nervous system functions including learning, memory, movement, control and modulation of cerebral blood flow [<xref rid="bib0255" ref-type="bibr">[51]</xref>, <xref rid="bib0260" ref-type="bibr">[52]</xref>, <xref rid="bib0265" ref-type="bibr">[53]</xref>] and thus very important in neurological functions. Acetylcholine level is controlled by Acetylcholinesterase (AchE), an enzyme that hydrolyse the neurotransmitter. Alteration in the activities of AchE may lead to undesirable effect on cholinergic transmission as well as progressive cognitive impairment [<xref rid="bib0270" ref-type="bibr">54</xref>]. Administration of nitrobenzene to rats cause drastic increase in the level of acetylcholinesterase activity in the three regions (cerebrum, cerebellum, and the mid brain) of the brain examined. Treatment with methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly attenuate this effect by decreasing greatly the activity of this enzyme in the three regions of the brain, especially in the striatum which contribute greatly in the neurodegenerative disorder known as Parkinson&#x02019;s disease. This established the ability of the extract to increase acetylcholine level in the synaptic cleft and influence cholinergic neurotransmission.</p><p id="par0210">Equally, the mechanism of action of some medicinal plants used in the management of Alzheimer&#x02019;s disease and memory deficit disorders has been linked to their modulatory effects on acetylcholinesterase activity which enhances learning and memory [<xref rid="bib0275" ref-type="bibr">55</xref>]. This cholinergic enzyme is highly implicated in cognitive dysfunction and pathogenesis of Alzheimer&#x02019;s disease, because clinical studies have shown that the sufferers of cognitive dysfunction, exhibited some behavioural improvements when cholinesterase inhibitor therapy commenced [<xref rid="bib0280" ref-type="bibr">56</xref>]. Thus, the ability of <italic>Vernonia amygdalina</italic> to increase the bioavailability of acetylcholine by inhibiting the activities of acetylcholinesterase suggested that the extract has memory enhancing effect.</p><p id="par0215">Dopamine also perform critical function in motor functions [<xref rid="bib0285" ref-type="bibr">57</xref>]. The depletion and consequent energy dysfunction of the mitochondria cascades affects the dopaminergic neurons, which requires greater energy for efficient function. In this study, nitrobenzene greatly reduced dopamine activity in the striatum, cerebellum and the mid brain. The severity of the clinical manifestations of parkinsonism (motor disturbance) and dementia is associated largely with the degeneration of dopaminergic neurons resulting in reduction of brain dopamine content [<xref rid="bib0290" ref-type="bibr">58</xref>]. Treatment with methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly increase the level of dopamine activity especially in the striatum. Certain plant nutrients serve as main precursors in the synthesis of neurotransmitters such as epinephrine, acetylcholine, serotonin, and dopamine [<xref rid="bib0295" ref-type="bibr">59</xref>].</p><p id="par0220">One of the beneficial effects of phytochemicals is their ability to contribute immensely to the general antioxidant defence system in various organs in the body including the brain, thereby influencing brain function, cognitive ability, and preventing oxidative stress [<xref rid="bib0080" ref-type="bibr">16</xref>]. In this study, exposure of rats to Nitrobenzene cause oxidative stress with significant decrease in GSH, CAT, and SOD. The reduction in the activities of these antioxidant enzymes is well-known to provide evidence about oxidative damage as a result of accumulation of ROS including H<sub>2</sub>O<sub>2</sub> which eventually leads to lipid peroxidation [<xref rid="bib0300" ref-type="bibr">60</xref>,<xref rid="bib0305" ref-type="bibr">61</xref>,<xref rid="bib0345" ref-type="bibr">69</xref>,<xref rid="bib0350" ref-type="bibr">70</xref>]. However, treatment with methanol leaf extract of <italic>Vernonia amygdalina</italic> or vitamin E significantly increase the activity levels of these enzymes. This result agrees with previous report that endogenous antioxidants enzymes such as catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPX), glutathione S-transferase (GST) play significant role in inhibiting neurodegeneration in the brain [<xref rid="bib0310" ref-type="bibr">62</xref>].</p><p id="par0225">Histological study shows the cytoarchitecture of three regions of the brain. There are marked alterations in morphological characteristics in the cerebrum, midbrain and cerebellum of the group of rats administered with nitrobenzene only. The control group and group treated with <italic>Vernonia amygdalina</italic> and vitamin E showed no changes or alterations in their morphological characteristics. The mid brain and cerebellum of the toxicant group showed observable gradual loss of cytoplasmic contents and degenerative changes like clustered pyknotic (irreversible condensation of the chromatin) pyramidal neurons was seen at the cerebral cortex. Apoptosis (programmed cell death) is characterized by pyknosis. Therefore, the feature exhibited in the cerebral cortex can be explained as altered rate of apoptosis, this can lead to excessive presence and accumulation of dead neuronal cells. This histological finding corroborates the biochemical results.</p></sec><sec id="sec0110"><label>5</label><title>Conclusion</title><p id="par0230">Data from this study further potentiate the beneficial effects of methanol leaf extract of <italic>Vernonia amygdalina</italic> in neurodegenerative disorders. The results obtained demonstrated with convincing evidence that behavioural deficit associated with administration of nitrobenzene in rats were markedly attenuated by methanol leaf extract of <italic>Vernonia amygdalina</italic>. In addition, the extract mitigated the molecular processes and pathological features associated with neurodegenerative disorders in the cerebrum, cerebellum, and midbrain <italic>via</italic> mechanisms related to its antioxidant, acetylcholinesterase suppression, lipid peroxidation inhibition, anti-inflammatory and neurobehavioural restoring properties. Thus, our data suggest the clinical significance of methanol leaf extract of <italic>Vernonia amygdalina</italic> in the prevention and management of neurodegenerative disorders with behavioural impairment.</p></sec><sec id="sec0115"><title>Funding</title><p id="par0235">This research was done using authors personal funds without specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></sec><sec id="sec00005"><title>CRediT authorship contribution statement</title><p id="par00005"><bold>Johnson O. Oladele:</bold> Conceptualization, Methodology, Data curation, Writing - original draft, Funding acquisition. <bold>Oyedotun M. Oyeleke:</bold> Supervision, Project administration, Writing - original draft, Funding acquisition. <bold>Oluwaseun T. Oladele:</bold> Methodology, Data curation, Writing - original draft, Funding acquisition. <bold>Monisola Olaniyan:</bold> Methodology, Data curation, Writing - original draft, Funding acquisition.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="par0240">The authors report no declarations of interest.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><label>1</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Dorsey</surname><given-names>E.R.</given-names></name><name><surname>Constantinescu</surname><given-names>R.</given-names></name><name><surname>Thompson</surname><given-names>J.P.</given-names></name><name><surname>Biglan</surname><given-names>K.L.M.</given-names></name><name><surname>Holloway</surname><given-names>R.G.</given-names></name><name><surname>Al Kieburtz</surname><given-names>K.E.</given-names></name></person-group><article-title>Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030</article-title><source>Neurology</source><volume>68</volume><year>2007</year><fpage>384</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">17082464</pub-id></element-citation></ref><ref id="bib0010"><label>2</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Okubadejo</surname><given-names>N.U.</given-names></name><name><surname>Ojo</surname><given-names>O.O.</given-names></name><name><surname>Oshinaike</surname><given-names>O.O.</given-names></name></person-group><article-title>Clinical profile of parkinsonism and parkinson&#x02019;s disease in Lagos, South Western Nigeria</article-title><source>BMC Neurol.</source><volume>10</volume><year>2010</year><fpage>1</fpage><pub-id pub-id-type="pmid">20051133</pub-id></element-citation></ref><ref id="bib0015"><label>3</label><element-citation publication-type="book" id="sbref0015"><person-group person-group-type="author"><name><surname>Parkinson Disease Foundation (PDF)</surname></name></person-group><chapter-title>Statistics on parkinson&#x02019;s</chapter-title><comment>[WWW Document]. URL</comment><year>2016</year><ext-link ext-link-type="uri" xlink:href="http://www.pdf.org/symptoms_statistics" id="intr0010">http://www.pdf.org/symptoms_statistics</ext-link></element-citation></ref><ref id="bib0020"><label>4</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C.</given-names></name><name><surname>El Khoury</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name></person-group><article-title>LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson&#x02019;s disease</article-title><source>Neurobiol. Dis.</source><volume>40</volume><year>2010</year><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2010.04.002</pub-id><pub-id pub-id-type="pmid">20382224</pub-id></element-citation></ref><ref id="bib0025"><label>5</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Helferich</surname><given-names>A.M.</given-names></name><name><surname>McLean</surname><given-names>P.J.</given-names></name><name><surname>Weishaupt</surname><given-names>J.H.</given-names></name><name><surname>Danzer</surname><given-names>K.M.</given-names></name></person-group><article-title>Commentary: alpha-synuclein interacts with SOD1 and promotes its oligomerization</article-title><source>J. Neurol. Neuromed.</source><volume>1</volume><year>2016</year><fpage>28</fpage><lpage>30</lpage></element-citation></ref><ref id="bib0030"><label>6</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Winslow</surname><given-names>A.R.</given-names></name><name><surname>Chen</surname><given-names>C.W.</given-names></name><name><surname>Corrochano</surname><given-names>S.</given-names></name></person-group><article-title>a-Synuclein impairs macroautophagy: implications for Parkinson&#x02019;s disease</article-title><source>J. Cell Biol.</source><volume>190</volume><year>2010</year><fpage>1023</fpage><lpage>1037</lpage><pub-id pub-id-type="pmid">20855506</pub-id></element-citation></ref><ref id="bib0035"><label>7</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R.S.</given-names></name><name><surname>Segawa</surname><given-names>E.</given-names></name><name><surname>Boyle</surname><given-names>P.A.</given-names></name></person-group><article-title>Psychology and aging the natural history of cognitive decline in Alzheimer&#x02019;s disease</article-title><source>Nat. Hist. Cognit. Decline Alzheimer&#x02019;s Dis.</source><volume>27</volume><year>2012</year><pub-id pub-id-type="doi">10.1037/a0029857</pub-id></element-citation></ref><ref id="bib0040"><label>8</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Gaugler</surname><given-names>J.</given-names></name><name><surname>James</surname><given-names>B.</given-names></name><name><surname>Johnson</surname><given-names>T.</given-names></name></person-group><article-title>2016 Alzheimer&#x02019;s disease facts and figures</article-title><source>Alzheimer&#x02019;s Dementia</source><volume>12</volume><year>2016</year><fpage>459</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2016.03.001</pub-id></element-citation></ref><ref id="bib0045"><label>9</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>K.</given-names></name><name><surname>Johnson</surname><given-names>G.</given-names></name></person-group><article-title>The role of Tau phosphorylation in the pathogenesis of Alzheimers disease</article-title><source>Curr. Alzheimer Res.</source><volume>3</volume><year>2006</year><fpage>449</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.2174/156720506779025279</pub-id><pub-id pub-id-type="pmid">17168644</pub-id></element-citation></ref><ref id="bib0050"><label>10</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M.P.</given-names></name><name><surname>Iii</surname><given-names>H.L.</given-names></name></person-group><article-title>AD and beta amyloid peptide</article-title><source>J. Alzheimers Dis.</source><volume>19</volume><year>2010</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-1221.Alzheimer</pub-id><pub-id pub-id-type="pmid">20061621</pub-id></element-citation></ref><ref id="bib0055"><label>11</label><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Pringsheim</surname><given-names>T.</given-names></name><name><surname>Jette</surname><given-names>N.</given-names></name><name><surname>Frolkis</surname><given-names>A.</given-names></name><name><surname>Steeves</surname><given-names>T.D.L.</given-names></name></person-group><article-title>The prevalence of Parkinson&#x02019;s disease: a systematic review and meta-analysis</article-title><source>Mov. Disord.</source><volume>29</volume><year>2014</year><fpage>1583</fpage><lpage>1590</lpage><pub-id pub-id-type="pmid">24976103</pub-id></element-citation></ref><ref id="bib0060"><label>12</label><element-citation publication-type="book" id="sbref0060"><person-group person-group-type="author"><name><surname>IPCS (International Programme on Chemical Safety)</surname></name></person-group><series>Nitrobenzene. Environmental Health Criteria</series><volume>vol. 230</volume><year>2003</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><comment>Available online at</comment><ext-link ext-link-type="uri" xlink:href="http://www.inchem.org/documents/ehc/ehc/ehc230.htm" id="intr0015">http://www.inchem.org/documents/ehc/ehc/ehc230.htm</ext-link></element-citation></ref><ref id="bib0065"><label>13</label><element-citation publication-type="book" id="sbref0065"><person-group person-group-type="author"><name><surname>RAR</surname></name></person-group><chapter-title>Part I, Environment European Union Risk Assessment Report Nitrobenzene</chapter-title><year>2007</year><fpage>2</fpage><lpage>106</lpage><comment>CAS# 98-95-3, Final Risk Assessment Report, Environmental Part (RAR, 2007)</comment><ext-link ext-link-type="uri" xlink:href="http://esis.jrc.ec.europa.eu/" id="intr0020">http://esis.jrc.ec.europa.eu/</ext-link></element-citation></ref><ref id="bib0070"><label>14</label><element-citation publication-type="book" id="sbref0070"><person-group person-group-type="author"><name><surname>ECHA (European Chemical Agency)</surname></name></person-group><chapter-title>Background Document to RAC Opinion on Nitrobenzene</chapter-title><year>2012</year><comment>ECHA/RAC/CLH-O-0000002350-87-01/A1</comment></element-citation></ref><ref id="bib0075"><label>15</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Costello</surname><given-names>S.</given-names></name><name><surname>Cockburn</surname><given-names>M.</given-names></name><name><surname>Bronstein</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Ritz</surname><given-names>B.</given-names></name></person-group><article-title>Parkinson&#x02019;s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California</article-title><source>Am. J. Epidemiol.</source><volume>169</volume><year>2009</year><fpage>919</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">19270050</pub-id></element-citation></ref><ref id="bib0080"><label>16</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Farombi</surname><given-names>E.O.</given-names></name><name><surname>Awogbindin</surname><given-names>I.O.</given-names></name><name><surname>Farombi</surname><given-names>T.H.</given-names></name><name><surname>Oladele</surname><given-names>J.O.</given-names></name><name><surname>Izomoh</surname><given-names>E.R.</given-names></name><name><surname>Aladelokun</surname><given-names>O.B.</given-names></name><name><surname>Ezekiel</surname><given-names>I.O.</given-names></name><name><surname>Adebambo</surname><given-names>O.I.</given-names></name><name><surname>Abah</surname><given-names>V.O.</given-names></name></person-group><article-title>Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson&#x02019;s disease</article-title><source>Neurotoxicology</source><volume>73</volume><year>2019</year><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">30930291</pub-id></element-citation></ref><ref id="bib0085"><label>17</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Oyewole</surname><given-names>O.I.</given-names></name><name><surname>Oladele</surname><given-names>J.O.</given-names></name><name><surname>Oladele</surname><given-names>O.T.</given-names></name></person-group><article-title>Methanolic leaf extract of <italic>Ficus exasperata</italic> leaf attenuates arsenate-mediated hepatic and renal oxidative stress in rats</article-title><source>Res. J. Health Sci.</source><volume>5</volume><issue>2</issue><year>2017</year><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.4314/rejhs.v5i2.7</pub-id></element-citation></ref><ref id="bib0090"><label>18</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Oyewole</surname><given-names>O.I.</given-names></name><name><surname>Olabiyi</surname><given-names>B.F.</given-names></name><name><surname>Oladele</surname><given-names>J.O.</given-names></name></person-group><article-title>Antioxidative potential of <italic>Ricinus communis</italic> leaf extract on cadmium-induced liver and brain toxicity in Rats</article-title><source>UNIOSUN J. Sci.</source><volume>2</volume><issue>2</issue><year>2017</year><fpage>84</fpage><lpage>90</lpage></element-citation></ref><ref id="bib0095"><label>19</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Erasto</surname><given-names>P.</given-names></name><name><surname>Grierson</surname><given-names>D.S.</given-names></name><name><surname>Afolayan</surname><given-names>A.J.</given-names></name></person-group><article-title>Bioactive sesquiterpenes lactones from the leaves of <italic>V. amygdalina</italic></article-title><source>J. Ethnopharmacol.</source><volume>106</volume><year>2006</year><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.12.016</pub-id><pub-id pub-id-type="pmid">16458461</pub-id></element-citation></ref><ref id="bib0100"><label>20</label><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Izeybigie</surname><given-names>E.B.</given-names></name></person-group><article-title>Discovery of water solubleanticancer agents (Edotides) from a vegetable found in Benin City, Nigeria</article-title><source>Exper. Biol. Med.</source><volume>228</volume><year>2003</year><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1177/153537020322800308</pub-id></element-citation></ref><ref id="bib0105"><label>21</label><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Cimanga</surname><given-names>R.K.</given-names></name><name><surname>Tona</surname><given-names>L.</given-names></name><name><surname>Mesia</surname><given-names>K.</given-names></name><name><surname>Musuamba</surname><given-names>C.T.</given-names></name><name><surname>De Bruyne</surname><given-names>T.</given-names></name><name><surname>Apers</surname><given-names>S.</given-names></name><name><surname>Hernan</surname><given-names>N.</given-names></name><name><surname>Miert</surname><given-names>V.S.</given-names></name><name><surname>Pieters</surname><given-names>L.</given-names></name><name><surname>Totte</surname><given-names>J.</given-names></name><name><surname>Vlietink</surname><given-names>A.J.</given-names></name></person-group><article-title><italic>In vitro</italic>antiplasmodia acivity of extravts and fractions of seven medicinal plants used in the democratic republic of Congo</article-title><source>J. Ethnopharmacol.</source><volume>93</volume><year>2004</year><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.02.022</pub-id><pub-id pub-id-type="pmid">15182900</pub-id></element-citation></ref><ref id="bib0110"><label>22</label><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Muraina</surname><given-names>I.A.</given-names></name><name><surname>Adaudi</surname><given-names>A.O.</given-names></name><name><surname>Mamman</surname><given-names>M.</given-names></name><name><surname>Kazeem</surname><given-names>H.M.</given-names></name><name><surname>Picard</surname><given-names>J.</given-names></name><name><surname>McGaw</surname><given-names>L.J.</given-names></name><name><surname>Eloff</surname><given-names>J.N.</given-names></name></person-group><article-title>Antimycoplasmal activity of some plant species from northern Nigeria compared to the currently used therapeutic agent</article-title><source>Pharm. Biol.</source><volume>48</volume><year>2010</year><fpage>1103</fpage><lpage>1107</lpage><pub-id pub-id-type="doi">10.3109/13880200903505633</pub-id><pub-id pub-id-type="pmid">20819025</pub-id></element-citation></ref><ref id="bib0115"><label>23</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Adesanoye</surname><given-names>O.A.</given-names></name><name><surname>Farombi</surname><given-names>E.O.</given-names></name></person-group><article-title>Hepatoprotective effects of <italic>V. amygdalina</italic> (<italic>Astereaceae</italic>) in rats treated with carbon tetrachloride</article-title><source>Exp. Toxicol. Pathol.</source><volume>62</volume><year>2010</year><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2009.05.008</pub-id><pub-id pub-id-type="pmid">19581077</pub-id></element-citation></ref><ref id="bib0120"><label>24</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>G.</given-names></name><name><surname>Abdurahman</surname><given-names>E.M.</given-names></name><name><surname>Ibrahim</surname><given-names>H.</given-names></name><name><surname>Ibrahim</surname><given-names>N.O.</given-names></name></person-group><article-title>Comparative cytomormological studies on the studies of <italic>V. amygdalina</italic> Del. and V. Kotschyama</article-title><source>Nig. J. Bot.</source><volume>23</volume><issue>1</issue><year>2010</year><fpage>133</fpage><lpage>142</lpage></element-citation></ref><ref id="bib0125"><label>25</label><element-citation publication-type="book" id="sbref0125"><person-group person-group-type="author"><name><surname>Harborne</surname><given-names>J.B.</given-names></name></person-group><chapter-title>Phytochemical Methods a Guide to Modern Techniques of Plant Analysis</chapter-title><year>1998</year><publisher-name>SSBM</publisher-name><publisher-loc>Berlin</publisher-loc></element-citation></ref><ref id="bib0130"><label>26</label><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Van Buren</surname><given-names>J.P.</given-names></name><name><surname>Robinson</surname><given-names>W.B.</given-names></name></person-group><article-title>Formation of complexes between protein and tannic acid</article-title><source>J. Agric. Food Chem.</source><volume>17</volume><year>1969</year><fpage>772</fpage><lpage>777</lpage></element-citation></ref><ref id="bib0135"><label>27</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Singleton</surname><given-names>V.L.</given-names></name><name><surname>Orthofer</surname><given-names>R.</given-names></name><name><surname>Lamuela-Raventos</surname><given-names>R.M.</given-names></name></person-group><article-title>Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin- Cioalteau reagent</article-title><source>Methods Enzymol.</source><volume>299</volume><year>1999</year><fpage>152</fpage><lpage>178</lpage></element-citation></ref><ref id="bib0140"><label>28</label><element-citation publication-type="book" id="sbref0140"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>N.M.</given-names></name></person-group><chapter-title>A Text Book of Pharmacognosy</chapter-title><year>1956</year><publisher-name>MacMilan Company</publisher-name><publisher-loc>New Delhi</publisher-loc><fpage>191</fpage></element-citation></ref><ref id="bib0145"><label>29</label><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Obadoni</surname><given-names>B.</given-names></name><name><surname>Ochuko</surname><given-names>P.</given-names></name></person-group><article-title>Phytochemical studies and comparative efficacy of the crude extracts of some haemostatic plants in Edo and Delta states of Nigeria</article-title><source>GJPAS</source><volume>8</volume><year>2002</year><fpage>203</fpage><lpage>208</lpage></element-citation></ref><ref id="bib0150"><label>30</label><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>Meda</surname><given-names>A.</given-names></name><name><surname>Lamien</surname><given-names>C.E.</given-names></name><name><surname>Romito</surname><given-names>M.</given-names></name><name><surname>Millogo</surname><given-names>J.</given-names></name><name><surname>Andnacoulma</surname><given-names>O.G.</given-names></name></person-group><article-title>Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activity</article-title><source>Food Chem.</source><volume>91</volume><year>2005</year><fpage>571</fpage><lpage>577</lpage></element-citation></ref><ref id="bib0155"><label>31</label><element-citation publication-type="book" id="sbref0155"><person-group person-group-type="author"><name><surname>National Research Council (NRC)</surname></name></person-group><chapter-title>Guide for the Care and Use of Laboratory Animals</chapter-title><edition>8th edition</edition><year>2011</year><publisher-name>The National Academies Press</publisher-name><pub-id pub-id-type="doi">10.17226/12910</pub-id></element-citation></ref><ref id="bib0160"><label>32</label><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Ellman</surname><given-names>G.L.</given-names></name><name><surname>Courtney</surname><given-names>K.D.</given-names></name><name><surname>Andres</surname><given-names>V.</given-names><suffix>Jr.</suffix></name><name><surname>Feather-Stone</surname><given-names>R.M.</given-names></name></person-group><article-title>A new and rapid colorimetric determination of acetylcholinesterase activity</article-title><source>Biochem. Pharmacol.</source><volume>7</volume><year>1961</year><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">13726518</pub-id></element-citation></ref><ref id="bib0165"><label>33</label><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>O.H.</given-names></name><name><surname>Rosenbrough</surname><given-names>N.J.</given-names></name><name><surname>Farr</surname><given-names>A.L.</given-names></name><name><surname>Randall</surname><given-names>R.J.</given-names></name></person-group><article-title>Protein measurement with the Folin phenol reagent</article-title><source>J. Biol. Chem.</source><volume>193</volume><year>1951</year><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">14907713</pub-id></element-citation></ref><ref id="bib0170"><label>34</label><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Green</surname><given-names>L.C.</given-names></name><name><surname>Wagner</surname><given-names>D.A.</given-names></name><name><surname>Glogowski</surname><given-names>J.</given-names></name><name><surname>Skipper</surname><given-names>P.L.</given-names></name><name><surname>Wishnok</surname><given-names>J.S.</given-names></name><name><surname>Tannenbaum</surname><given-names>S.R.</given-names></name></person-group><article-title>Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids</article-title><source>Anal. Biochem.</source><volume>126</volume><year>1982</year><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">7181105</pub-id></element-citation></ref><ref id="bib0175"><label>35</label><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Quanmin</surname><given-names>L.</given-names></name></person-group><article-title>Spectrophotometric determination of dopamine hydrochloride in pharmaceutical, banana, urine and serum samples by potassium ferricyanide-Fe (III)</article-title><source>Anal. Sci.</source><volume>25</volume><issue>12</issue><year>2009</year><fpage>1451</fpage><lpage>1455</lpage><pub-id pub-id-type="pmid">20009333</pub-id></element-citation></ref><ref id="bib0180"><label>36</label><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Granell</surname><given-names>S.</given-names></name><name><surname>Gironella</surname><given-names>M.</given-names></name><name><surname>Bulbena</surname><given-names>O.</given-names></name><name><surname>Panes</surname><given-names>J.</given-names></name><name><surname>Mauri</surname><given-names>M.</given-names></name><name><surname>Sabater</surname><given-names>L.</given-names></name><name><surname>Aparisi</surname><given-names>L.</given-names></name><name><surname>Gelpi</surname><given-names>E.</given-names></name><name><surname>Closa</surname><given-names>D.</given-names></name></person-group><article-title>Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis</article-title><source>Crit. Care Med.</source><volume>31</volume><year>2003</year><fpage>525</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">12576961</pub-id></element-citation></ref><ref id="bib0185"><label>37</label><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>R.</given-names></name><name><surname>Kale</surname><given-names>R.K.</given-names></name></person-group><article-title>Effect of calmodulin antagonist on radiation induced lipid peroxidation in microsomes</article-title><source>Int. J. Radiat. Biol.</source><volume>58</volume><year>1990</year><fpage>733</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1080/09553009014552121</pub-id><pub-id pub-id-type="pmid">1977818</pub-id></element-citation></ref><ref id="bib0190"><label>38</label><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>H.P.</given-names></name><name><surname>Fridovich</surname><given-names>I.</given-names></name></person-group><article-title>The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase</article-title><source>J. Biol. Chem.</source><volume>247</volume><year>1972</year><fpage>3170</fpage><lpage>3175</lpage><pub-id pub-id-type="pmid">4623845</pub-id></element-citation></ref><ref id="bib0195"><label>39</label><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Buetler</surname><given-names>E.</given-names></name><name><surname>Duron</surname><given-names>O.</given-names></name><name><surname>Kelly</surname><given-names>B.M.</given-names></name></person-group><article-title>Improved method for the determination of blood glutathione</article-title><source>J. Lab. Clin. Med.</source><volume>61</volume><year>1963</year><fpage>882</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1097/00003072-199111000-00028</pub-id><pub-id pub-id-type="pmid">13967893</pub-id></element-citation></ref><ref id="bib0200"><label>40</label><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Wolff</surname><given-names>S.P.</given-names></name></person-group><article-title>Ferrous ion oxidation in the presence of ferric ion indicator xylenol orange for measurement of hydroperoxides</article-title><source>Methods Enzym.</source><volume>233</volume><year>1994</year><fpage>182</fpage><lpage>189</lpage></element-citation></ref><ref id="bib0205"><label>41</label><element-citation publication-type="book" id="sbref0205"><person-group person-group-type="author"><name><surname>Clairborne</surname><given-names>A.</given-names></name></person-group><chapter-title>Catalase activity. Handbook of Methods for Oxygen Radical Research</chapter-title><year>1995</year><publisher-name>CRC Press</publisher-name><publisher-loc>Florida</publisher-loc></element-citation></ref><ref id="bib0210"><label>42</label><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Kaizer</surname><given-names>R.R.</given-names></name><name><surname>Corr&#x000ea;a</surname><given-names>M.C.</given-names></name><name><surname>Spanevello</surname><given-names>R.M.</given-names></name><name><surname>Morsch</surname><given-names>V.M.</given-names></name><name><surname>Mazzanti</surname><given-names>C.M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>J.F.</given-names></name></person-group><article-title>Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions</article-title><source>J. Inorg. Biochem.</source><volume>99</volume><year>2005</year><fpage>1865</fpage><lpage>1870</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2005.06.015</pub-id><pub-id pub-id-type="pmid">16055195</pub-id></element-citation></ref><ref id="bib0215"><label>43</label><element-citation publication-type="journal" id="sbref0215"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>G.</given-names></name><name><surname>Pu</surname><given-names>X.</given-names></name><name><surname>Lei</surname><given-names>L.</given-names></name></person-group><article-title>Tubuloside B from Cistanche salsa rescues the PC12 neuronal cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis and oxidative stress</article-title><source>Planta Med.</source><volume>68</volume><year>2002</year><fpage>966</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1055/s-2002-35667</pub-id><pub-id pub-id-type="pmid">12451484</pub-id></element-citation></ref><ref id="bib0220"><label>44</label><element-citation publication-type="journal" id="sbref0220"><person-group person-group-type="author"><name><surname>Oyewole</surname><given-names>O.I.</given-names></name><name><surname>Oladele</surname><given-names>J.O.</given-names></name></person-group><article-title>Changes in activities of tissues enzymes in rats administered <italic>Ficus exasperata</italic> leaf extract</article-title><source>Int. J. Biol. Chem. Sci.</source><volume>11</volume><issue>1</issue><year>2017</year><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.4314/ijbcs.v11i1.29</pub-id></element-citation></ref><ref id="bib0225"><label>45</label><element-citation publication-type="journal" id="sbref0225"><person-group person-group-type="author"><name><surname>Oladele</surname><given-names>J.O.</given-names></name><name><surname>Oyewole</surname><given-names>O.I.</given-names></name><name><surname>Bello</surname><given-names>O.K.</given-names></name><name><surname>Oladele</surname><given-names>O.T.</given-names></name></person-group><article-title>Assessment of protective potentials of <italic>Ficus exasperata</italic> leaf on arsenate-mediated dyslipidemia and oxidative damage in rat&#x02019;s brain</article-title><source>J. Basic Appl. Res.</source><volume>3</volume><issue>3</issue><year>2017</year><fpage>77</fpage><lpage>82</lpage></element-citation></ref><ref id="bib0230"><label>46</label><element-citation publication-type="journal" id="sbref0230"><person-group person-group-type="author"><name><surname>Riemann</surname><given-names>B.L.</given-names></name><name><surname>Lephart</surname><given-names>S.M.</given-names></name></person-group><article-title>The sensorimotor system, Part I: the physiologic basis of functional joint stability</article-title><source>J. Athl. Train.</source><volume>37</volume><year>2002</year><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">16558670</pub-id></element-citation></ref><ref id="bib0235"><label>47</label><element-citation publication-type="journal" id="sbref0235"><person-group person-group-type="author"><name><surname>Adedara</surname><given-names>I.A.</given-names></name><name><surname>Rosemberg</surname><given-names>D.B.</given-names></name><name><surname>de Souza</surname><given-names>D.</given-names></name><name><surname>Farombi</surname><given-names>E.O.</given-names></name><name><surname>Aschner</surname><given-names>M.</given-names></name><name><surname>Souza</surname><given-names>D.O.</given-names></name><name><surname>Rocha</surname><given-names>J.B.T.</given-names></name></person-group><article-title>Neurobehavioral and biochemical changes in Nauphoetacinerea following dietary exposure to chlorpyrifos</article-title><source>Pestic. Biochem. Physiol.</source><volume>130</volume><year>2016</year><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">27155480</pub-id></element-citation></ref><ref id="bib0240"><label>48</label><element-citation publication-type="journal" id="sbref0240"><person-group person-group-type="author"><name><surname>Tartaglione</surname><given-names>A.M.</given-names></name><name><surname>Armida</surname><given-names>M.</given-names></name><name><surname>Potenza</surname><given-names>R.L.</given-names></name><name><surname>Pezzola</surname><given-names>A.</given-names></name><name><surname>Popoli</surname><given-names>P.</given-names></name><name><surname>Calamandrei</surname><given-names>G.</given-names></name></person-group><article-title>Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington&#x02019;s disease</article-title><source>Behav. Brain Res.</source><volume>313</volume><year>2016</year><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">27374158</pub-id></element-citation></ref><ref id="bib0245"><label>49</label><element-citation publication-type="journal" id="sbref0245"><person-group person-group-type="author"><name><surname>Owoeye</surname><given-names>O.</given-names></name><name><surname>Gabriel</surname><given-names>M.O.</given-names></name></person-group><article-title>Evaluation of neuroprotective effect of Hibiscus sabdariffa Linn. aqueous extract against ischaemic-reperfusion insult by bilateral common carotid artery occlusion in adult male rats</article-title><source>Niger. J. Physiol. Sci.</source><volume>32</volume><year>2017</year><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">29134984</pub-id></element-citation></ref><ref id="bib0250"><label>50</label><element-citation publication-type="journal" id="sbref0250"><person-group person-group-type="author"><name><surname>Layer</surname><given-names>A.</given-names></name><name><surname>G&#x000f3;mez-pinilla</surname><given-names>F.</given-names></name></person-group><article-title>Brain foods: the effects of nutrients on brain function</article-title><source>Nat. Rev. Neurosci.</source><volume>9</volume><issue>July</issue><year>2008</year></element-citation></ref><ref id="bib0255"><label>51</label><element-citation publication-type="journal" id="sbref0255"><person-group person-group-type="author"><name><surname>Kiehn</surname><given-names>O.</given-names></name></person-group><article-title>Locomotor circuits in the mammalian spinal cord</article-title><source>Annu. Rev. Neurosci.</source><volume>29</volume><issue>1</issue><year>2006</year><fpage>279</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.112910</pub-id><pub-id pub-id-type="pmid">16776587</pub-id></element-citation></ref><ref id="bib0260"><label>52</label><element-citation publication-type="journal" id="sbref0260"><person-group person-group-type="author"><name><surname>R&#x000f6;sser</surname><given-names>N.</given-names></name><name><surname>Fl&#x000f6;el</surname><given-names>A.</given-names></name></person-group><article-title>Levodopa improves procedural motor learning in chronic stroke patients</article-title><source>Klin. Neurophysiol.</source><volume>39</volume><issue>01</issue><year>2008</year><pub-id pub-id-type="doi">10.1055/s-2008-1072809</pub-id></element-citation></ref><ref id="bib0265"><label>53</label><element-citation publication-type="journal" id="sbref0265"><person-group person-group-type="author"><name><surname>Jolitha</surname><given-names>A.B.</given-names></name><name><surname>Subramanyam</surname><given-names>M.V.V.</given-names></name><name><surname>Asha Devi</surname><given-names>S.</given-names></name></person-group><article-title>Age-related responses of the rat cerebral cortex: influence of vitamin E and exercise on the cholinergic system</article-title><source>Biogerontology</source><volume>10</volume><issue>1</issue><year>2008</year><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1007/s10522-008-9154-6</pub-id><pub-id pub-id-type="pmid">18560990</pub-id></element-citation></ref><ref id="bib0270"><label>54</label><element-citation publication-type="journal" id="sbref0270"><person-group person-group-type="author"><name><surname>Abdalla</surname><given-names>F.H.</given-names></name><name><surname>Cardoso</surname><given-names>A.M.</given-names></name><name><surname>Pereira</surname><given-names>L.B.</given-names></name><name><surname>Schmatz</surname><given-names>R.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>J.F.</given-names></name><name><surname>Stefanello</surname><given-names>N.</given-names></name><name><surname>Fiorenza</surname><given-names>A.M.</given-names></name><name><surname>Gutieeres</surname><given-names>J.M.</given-names></name><name><surname>Serres</surname><given-names>J.D.</given-names></name><name><surname>Zanini</surname><given-names>D.</given-names></name><name><surname>Pimentel</surname><given-names>V.C.</given-names></name><name><surname>Vieira</surname><given-names>J.M.</given-names></name><name><surname>Schetinger</surname><given-names>M.R.S.</given-names></name><name><surname>Morsch</surname><given-names>V.M.</given-names></name><name><surname>Mazzanti</surname><given-names>C.M.</given-names></name></person-group><article-title>Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats</article-title><source>Mol. Cell. Biochem.</source><volume>381</volume><issue>1&#x02013;2</issue><year>2013</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s11010-013-1659-x</pub-id><pub-id pub-id-type="pmid">23797318</pub-id></element-citation></ref><ref id="bib0275"><label>55</label><element-citation publication-type="journal" id="sbref0275"><person-group person-group-type="author"><name><surname>Akram</surname><given-names>M.</given-names></name><name><surname>Nawaz</surname><given-names>A.</given-names></name></person-group><article-title>Effects of medicinal plants on Alzheimer&#x02019;s disease and memory deficits</article-title><source>Neural Regen. Res.</source><volume>12</volume><issue>4</issue><year>2017</year></element-citation></ref><ref id="bib0280"><label>56</label><element-citation publication-type="journal" id="sbref0280"><person-group person-group-type="author"><name><surname>Adefegha</surname><given-names>S.</given-names></name><name><surname>Oboh</surname><given-names>G.</given-names></name><name><surname>Oyeleye</surname><given-names>S.</given-names></name><name><surname>Dada</surname><given-names>F.</given-names></name><name><surname>Ejakpovi</surname><given-names>I.</given-names></name><name><surname>Boligon</surname><given-names>A.</given-names></name></person-group><article-title>Cognitive enhancing and antioxidative potentials of Velvet beans (<italic>Mucuna pruriens</italic>) and Horseradish (<italic>Moringa oleifera</italic>) seeds extracts: a comparative study</article-title><source>J. Food Biochem.</source><volume>41</volume><year>2017</year><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="bib0285"><label>57</label><element-citation publication-type="journal" id="sbref0285"><person-group person-group-type="author"><name><surname>Ayano</surname><given-names>G.</given-names></name></person-group><article-title>Dopamine: receptors, functions, synthesis, pathways, locations and mental disorders: review of literatures</article-title><source>J. Ment. Disord. Treat.</source><volume>2</volume><year>2016</year><fpage>120</fpage><pub-id pub-id-type="doi">10.4172/2471-271X.1000120</pub-id></element-citation></ref><ref id="bib0290"><label>58</label><element-citation publication-type="journal" id="sbref0290"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.M.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Kam</surname><given-names>W.</given-names></name><name><surname>Wilson</surname><given-names>B.</given-names></name><name><surname>Hong</surname><given-names>J.S.</given-names></name></person-group><article-title>Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson&#x02019;s disease</article-title><source>Environ. Health Persp.</source><volume>119</volume><year>2011</year><fpage>807</fpage><lpage>814</lpage></element-citation></ref><ref id="bib0295"><label>59</label><element-citation publication-type="book" id="sbref0295"><person-group person-group-type="author"><name><surname>Ebuehi</surname><given-names>O.</given-names></name></person-group><chapter-title>Nutrients and neurotransmitters: the chemicals of life in the brain</chapter-title><source>10th Inaugural Lecture Series, Delivered at Main Auditorium</source><conf-name>Univ. of Lagos, University of Lagos Press, Lagos, Nigeria, March 21</conf-name><year>2012</year><fpage>96</fpage></element-citation></ref><ref id="bib0300"><label>60</label><element-citation publication-type="journal" id="sbref0300"><person-group person-group-type="author"><name><surname>Oladele</surname><given-names>J.O.</given-names></name><name><surname>Oyewole</surname><given-names>O.I.</given-names></name><name><surname>Bello</surname><given-names>O.K.</given-names></name><name><surname>Oladele</surname><given-names>O.T.</given-names></name></person-group><article-title>Hepatoprotective effect of aqueous extract of <italic>Telfairia occidentalis</italic> on cadmium chloride-induced oxidative stress and hepatotoxicity in rats</article-title><source>J. Drug Des. Med. Chem.</source><volume>3</volume><issue>3</issue><year>2017</year><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.11648/j.jddmc.20170303.11</pub-id></element-citation></ref><ref id="bib0305"><label>61</label><element-citation publication-type="journal" id="sbref0305"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>M.</given-names></name><name><surname>Jomova</surname><given-names>K.</given-names></name><name><surname>Rhodes</surname><given-names>C.J.</given-names></name><name><surname>Ku&#x0010d;a</surname><given-names>K.</given-names></name><name><surname>Musilek</surname><given-names>K.</given-names></name></person-group><article-title>Redox- and non-redox metal-induced formation of free radicals and their role in human disease</article-title><source>Arch. Toxicol.</source><volume>90</volume><year>2016</year><fpage>1</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">26343967</pub-id></element-citation></ref><ref id="bib0310"><label>62</label><element-citation publication-type="journal" id="sbref0310"><person-group person-group-type="author"><name><surname>Abushouk</surname><given-names>A.I.</given-names></name></person-group><article-title>Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: future applications in Parkinson&#x02019;s disease</article-title><source>Biomed. Pharmacother.</source><year>2016</year><pub-id pub-id-type="doi">10.1016/j.biopha.2016.11.074</pub-id></element-citation></ref><ref id="bib0315"><label>63</label><element-citation publication-type="book" id="sbref0315"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Jankovic</surname><given-names>J.</given-names></name></person-group><chapter-title>The Genetics of Parkinson Disease. Ageing Research Reviews</chapter-title><year>2018</year><pub-id pub-id-type="doi">10.1016/j.arr.2017.12.007</pub-id></element-citation></ref><ref id="bib0320"><label>64</label><element-citation publication-type="journal" id="sbref0320"><person-group person-group-type="author"><name><surname>Pankratz</surname><given-names>N.</given-names></name><name><surname>Nichols</surname><given-names>W.C.</given-names></name><name><surname>Uniacke</surname><given-names>S.K.</given-names></name><name><surname>Halter</surname><given-names>C.</given-names></name><name><surname>Murrell</surname><given-names>J.</given-names></name><name><surname>Rudolph</surname><given-names>A.</given-names></name><name><surname>Shults</surname><given-names>C.W.</given-names></name><name><surname>Conneally</surname><given-names>P.M.</given-names></name><name><surname>Foroud</surname><given-names>T.</given-names></name><name><surname>the Parkinson Study Group</surname></name></person-group><article-title>Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families</article-title><source>Hum. Mol. Genet.</source><volume>12</volume><issue>20</issue><year>2003</year><fpage>2599</fpage><lpage>2608</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg270</pub-id><pub-id pub-id-type="pmid">12925570</pub-id></element-citation></ref><ref id="bib0325"><label>65</label><element-citation publication-type="journal" id="sbref0325"><person-group person-group-type="author"><name><surname>Imafidon</surname><given-names>C.E.</given-names></name><name><surname>Olukiran</surname><given-names>O.S.</given-names></name><name><surname>Ogundipe</surname><given-names>D.J.</given-names></name><name><surname>Eluwole</surname><given-names>A.O.</given-names></name><name><surname>Adekunle</surname><given-names>I.A.</given-names></name><name><surname>Oke</surname><given-names>G.O.</given-names></name></person-group><article-title>Acetonic extract of <italic>Vernonia amygdalina</italic> (Del.) attenuates Cd-induced liver injury: potential application in adjuvant heavy metal therapy</article-title><source>Toxicol. Rep.</source><volume>5</volume><year>2018</year><fpage>324</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2018.02.009</pub-id><pub-id pub-id-type="pmid">29854601</pub-id></element-citation></ref><ref id="bib0330"><label>66</label><element-citation publication-type="journal" id="sbref0330"><person-group person-group-type="author"><name><surname>Adefisayo</surname><given-names>M.A.</given-names></name><name><surname>Akomolafe</surname><given-names>R.O.</given-names></name><name><surname>Akinsomisoye</surname><given-names>S.O.</given-names></name><name><surname>Alabi</surname><given-names>Q.K.</given-names></name><name><surname>Ogundipe</surname><given-names>O.L.</given-names></name><name><surname>Omole</surname><given-names>J.G.</given-names></name><name><surname>Olamilosoye</surname><given-names>K.P.</given-names></name></person-group><article-title>Gastro-protective effect of methanol extract of <italic>Vernonia amygdalina</italic> (del.) leaf on aspirin-induced gastric ulcer in Wistar rats</article-title><source>Toxicol. Rep.</source><volume>4</volume><year>2017</year><fpage>625</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2017.11.004</pub-id><pub-id pub-id-type="pmid">29657922</pub-id></element-citation></ref><ref id="bib0335"><label>67</label><element-citation publication-type="journal" id="sbref0335"><person-group person-group-type="author"><name><surname>Varmazyari</surname><given-names>A.</given-names></name><name><surname>Taghizadehghalehjoughi</surname><given-names>A.</given-names></name><name><surname>Sevim</surname><given-names>C.</given-names></name><name><surname>Baris</surname><given-names>O.</given-names></name><name><surname>Eser</surname><given-names>G.</given-names></name><name><surname>Yildirim</surname><given-names>S.</given-names></name><name><surname>Hacimuftuoglu</surname><given-names>A.</given-names></name><name><surname>Buha</surname><given-names>A.</given-names></name><name><surname>Wallace</surname><given-names>D.R.</given-names></name><name><surname>Tsatsakis</surname><given-names>A.</given-names></name><name><surname>Aschner</surname><given-names>M.</given-names></name><name><surname>Mezhuev</surname><given-names>Y.</given-names></name></person-group><article-title>Cadmium sulfide-induced toxicity in the cortex and cerebellum: <italic>in vitro</italic> and <italic>in vivo</italic> studies</article-title><source>Toxicol. Rep.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.toxrep.2020.04.011</pub-id></element-citation></ref><ref id="bib0340"><label>68</label><element-citation publication-type="journal" id="sbref0340"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>T.</given-names></name><name><surname>Tsatsakis</surname><given-names>A.</given-names></name><name><surname>Santamar&#x000ed;a</surname><given-names>A.</given-names></name><name><surname>Soare</surname><given-names>F.A.A.</given-names></name><name><surname>Tinkov</surname><given-names>A.A.</given-names></name><name><surname>Docea</surname><given-names>A.O.</given-names></name><name><surname>Skalny</surname><given-names>A.</given-names></name><name><surname>Bowman</surname><given-names>A.B.</given-names></name><name><surname>Aschner</surname><given-names>M.</given-names></name></person-group><article-title>Chronic exposure to methylmercury induces puncta formation in cephalic dopaminergic neurons in Caenorhabditis elegans</article-title><source>Neurotoxicology</source><volume>77</volume><year>2020</year><fpage>105</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2020.01.003</pub-id><pub-id pub-id-type="pmid">31935438</pub-id></element-citation></ref><ref id="bib0345"><label>69</label><element-citation publication-type="journal" id="sbref0345"><person-group person-group-type="author"><name><surname>Hashemzaei</surname><given-names>M.</given-names></name><name><surname>Mamoulakis</surname><given-names>C.</given-names></name><name><surname>Tsarouhas</surname><given-names>K.</given-names></name><name><surname>Georgiadis</surname><given-names>G.</given-names></name><name><surname>Lazopoulos</surname><given-names>G.</given-names></name><name><surname>Tsatsakis</surname><given-names>A.</given-names></name><name><surname>Asrami</surname><given-names>E.S.</given-names></name><name><surname>Rezaee</surname><given-names>R.</given-names></name></person-group><article-title>Crocin: a fighter against inflammation and pain</article-title><source>Food Chem. Toxicol.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.fct.2020.111521</pub-id></element-citation></ref><ref id="bib0350"><label>70</label><element-citation publication-type="journal" id="sbref0350"><person-group person-group-type="author"><name><surname>Panieri</surname><given-names>E.</given-names></name><name><surname>Buha</surname><given-names>A.</given-names></name><name><surname>Telkoparan-Akillilar</surname><given-names>P.</given-names></name><name><surname>Cevik</surname><given-names>D.</given-names></name><name><surname>Kouretas</surname><given-names>D.</given-names></name><name><surname>Veskoukis</surname><given-names>A.</given-names></name><name><surname>Skaperda</surname><given-names>Z.</given-names></name><name><surname>Tsatsakis</surname><given-names>A.</given-names></name><name><surname>Wallace</surname><given-names>D.</given-names></name><name><surname>Suzen</surname><given-names>S.</given-names></name><name><surname>Saso</surname><given-names>L.</given-names></name></person-group><article-title>Potential applications of NRF2 modulators in cancer therapy</article-title><source>Antioxidants</source><volume>9</volume><year>2020</year><fpage>193</fpage><pub-id pub-id-type="doi">10.3390/antiox9030193</pub-id></element-citation></ref></ref-list><sec id="sec0125" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="par0255">The following is Supplementary data to this article:<supplementary-material content-type="local-data" id="upi0005"><media xlink:href="mmc1.zip"/></supplementary-material></p></sec><ack id="ack0005"><title>Acknowledgments</title><p>The authors wish to appreciate the technical supports of Mr. Adeleke Opeyemi Samson of the Department of Anatomy, College of Health Sciences, Osun State University, Osogbo, Nigeria.</p></ack><fn-group><fn id="sec0120" fn-type="supplementary-material"><label>Appendix A</label><p id="par0250">Supplementary material related to this article can be found, in the online version, at doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxrep.2020.09.005" id="intr0005">https://doi.org/10.1016/j.toxrep.2020.09.005</ext-link>.</p></fn></fn-group></back></article>